We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

107 hedge funds and large institutions have $230M invested in Voyager Therapeutics in 2023 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more call options, than puts

Call options by funds: $386K | Put options by funds: $200K

9% more capital invested

Capital invested by funds: $211M → $230M (+$18.4M)

7% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 30

0.22% less ownership

Funds ownership: 62.03% → 61.81% (-0.22%)

3% less funds holding

Funds holding: 110 → 107 (-3)

13% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 23

Holders
107
Holders Change
-3
Holders Change %
-2.73%
% of All Funds
1.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
32
Reduced
30
Closed
23
Calls
$386K
Puts
$200K
Net Calls
+$186K
Net Calls Change
+$566K

Top Buyers

Rank Fund Capital Flow
1
AQR Capital Management
AQR Capital Management
Connecticut
+$3.2M
2
Morgan Stanley
Morgan Stanley
New York
+$1.4M
3
BCM
Bridgeway Capital Management
Texas
+$1.31M
4
AACP
Advantage Alpha Capital Partners
California
+$1.28M
5
BlackRock
BlackRock
New York
+$1.21M

Top Sellers

Rank Fund Capital Flow
1
HIM
Hillsdale Investment Management
Ontario, Canada
-$2.85M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.6M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.6M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.54M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$1.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$35.8M +$421K +58,000 +1%
EC
2
EcoR1 Capital
California
$32.5M – – –
BlackRock
3
BlackRock
New York
$22.2M +$1.21M +167,291 +7%
Vanguard Group
4
Vanguard Group
Pennsylvania
$21.4M +$346K +47,711 +2%
FCM
5
Farallon Capital Management
California
$10.9M – – –
EAM
6
Erste Asset Management
Austria
$9M – – –
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$8.48M -$1.23M -169,301 -14%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$7.87M +$1.11M +153,291 +20%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$5.73M +$232K +31,933 +5%
AQR Capital Management
10
AQR Capital Management
Connecticut
$5.4M +$3.2M +440,465 +222%
State Street
11
State Street
Massachusetts
$5.23M +$273K +37,583 +6%
Federated Hermes
12
Federated Hermes
Pennsylvania
$4.66M -$234K -32,309 -6%
Morgan Stanley
13
Morgan Stanley
New York
$4.11M +$1.4M +192,752 +66%
American Century Companies
14
American Century Companies
Missouri
$3.97M +$1.14M +157,324 +50%
Acadian Asset Management
15
Acadian Asset Management
Massachusetts
$3.52M -$1.54M -212,342 -34%
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$3.43M -$1.6M -220,079 -35%
GC
17
Globeflex Capital
California
$2.8M -$887K -122,305 -27%
JP Morgan Chase
18
JP Morgan Chase
New York
$2.73M +$61.9K +8,537 +3%
Northern Trust
19
Northern Trust
Illinois
$2.66M +$88.5K +12,195 +4%
IC
20
Ikarian Capital
Texas
$2.58M – – –
FT
21
Fiduciary Trust
Massachusetts
$2.19M – – –
Bank of New York Mellon
22
Bank of New York Mellon
New York
$2.13M +$436K +60,038 +31%
KAS
23
Kestra Advisory Services
Texas
$1.82M +$650K +89,598 +71%
ACM
24
ADAR1 Capital Management
Texas
$1.57M +$1.35M +185,894 New
Renaissance Technologies
25
Renaissance Technologies
New York
$1.54M -$1.6M -220,500 -55%
1
2 3 4 5

VYGR Hedge Fund Activity: Q4 2023 in Review

107 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q4 2023, worth a combined $230M — up 8.7% from $211M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of VYGR and 20 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 32 added.

The largest buyer was AQR Capital Management, adding an estimated $3.2M. The largest seller was Hillsdale Investment Management, exiting entirely with an estimated $2.85M sold.

  • 107 institutional investors held Voyager Therapeutics (VYGR) as of Q4 2023, down from 110 in Q3 2023.
  • Funds reported $230M of Voyager Therapeutics stock for Q4 2023, up 8.7% quarter-over-quarter.
  • 20 funds opened new Voyager Therapeutics positions in Q4 2023 and 23 closed out, a net change of -3 holders.
  • The largest Voyager Therapeutics buyer in Q4 2023 was AQR Capital Management, an estimated $3.2M added.
  • The largest Voyager Therapeutics seller in Q4 2023 was Hillsdale Investment Management, an estimated $2.85M sold.

Based on aggregated 13F filings for Q4 2023.